{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:14:13Z","timestamp":1751429653452,"version":"3.41.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Science and Technology Bureau Municipal-University (Institute) Joint Funding Project","award":["2024A03J0585"],"award-info":[{"award-number":["2024A03J0585"]}]},{"name":"Guangdong Provincial Health Commission Funding Project","award":["A2019342"],"award-info":[{"award-number":["A2019342"]}]},{"name":"Guangzhou Municipal Health Commission Funding Project","award":["20221A011046"],"award-info":[{"award-number":["20221A011046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04091-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:47:34Z","timestamp":1751377654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sputum microbiota profiles of patients with rifampicin-resistant tuberculosis during the intensive-phase treatment"],"prefix":"10.1186","volume":"25","author":[{"given":"Xingshan","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bitong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"4091_CR1","volume-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva: World Health Organization; 2024."},{"issue":"5","key":"4091_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jiph.2018.04.005","volume":"11","author":"MT Zaw","year":"2018","unstructured":"Zaw MT, Emran NA, Lin Z. Mutations inside rifampicin-resistance determining region of RpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis. J Infect Public Health. 2018;11(5):605\u201310. https:\/\/doi.org\/10.1016\/j.jiph.2018.04.005.","journal-title":"J Infect Public Health"},{"issue":"1","key":"4091_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12931-023-02652-7","volume":"25","author":"Z Yuan","year":"2024","unstructured":"Yuan Z, Kang Y, Mo C, Huang S, Qin F, Zhang J, et al. Causal relationship between gut microbiota and tuberculosis: a bidirectional two-sample Mendelian randomization analysis. Respir Res. 2024;25(1):16. https:\/\/doi.org\/10.1186\/s12931-023-02652-7.","journal-title":"Respir Res"},{"key":"4091_CR4","doi-asserted-by":"publisher","first-page":"836987","DOI":"10.3389\/fcimb.2022.836987","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang Y, Deng Y, Liu N, Chen Y, Jiang Y, Teng Z, et al. Alterations in the gut Microbiome of individuals with tuberculosis of different disease States. Front Cell Infect Microbiol. 2022;12:836987. https:\/\/doi.org\/10.3389\/fcimb.2022.836987.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4091_CR5","doi-asserted-by":"publisher","first-page":"24486","DOI":"10.1038\/s41598-021-04271-y","volume":"11","author":"DP Kateete","year":"2021","unstructured":"Kateete DP, Mbabazi MM, Nakazzi F, Katabazi FA, Kigozi E, Ssengooba W, et al. Sputum microbiota profiles of treatment-na\u00efve TB patients in Uganda before and during first-line therapy. Sci Rep. 2021;11(1):24486. https:\/\/doi.org\/10.1038\/s41598-021-04271-y.","journal-title":"Sci Rep"},{"key":"4091_CR6","doi-asserted-by":"publisher","first-page":"1024867","DOI":"10.3389\/fcimb.2022.1024867","volume":"12","author":"X Xia","year":"2022","unstructured":"Xia X, Chen J, Cheng Y, Chen F, Lu H, Liu J, et al. Comparative analysis of the lung microbiota in patients with respiratory infections, tuberculosis, and lung cancer: A preliminary study. Front Cell Infect Microbiol. 2022;12:1024867. https:\/\/doi.org\/10.3389\/fcimb.2022.1024867.","journal-title":"Front Cell Infect Microbiol"},{"key":"4091_CR7","doi-asserted-by":"publisher","unstructured":"Li L, Zhang J, Li Z, Zhang C, Bi J, Zhou J et al. Airway microbiota is associated with the severity of non-CF bronchiectasis. 2021;15(2):154\u201362. https:\/\/doi.org\/10.1111\/crj.13279.","DOI":"10.1111\/crj.13279"},{"key":"4091_CR8","doi-asserted-by":"publisher","unstructured":"Hu Y, Cheng M, Liu B, Dong J, Sun L, Yang J. Metagenomic analysis of the lung Microbiome in pulmonary tuberculosis - a pilot study. 2020;9(1):1444\u201352. https:\/\/doi.org\/10.1080\/22221751.2020.1783188.","DOI":"10.1080\/22221751.2020.1783188"},{"key":"4091_CR9","doi-asserted-by":"publisher","first-page":"112108","DOI":"10.1016\/j.biopha.2021.112108","volume":"143","author":"T Shah","year":"2021","unstructured":"Shah T, Shah Z, Baloch Z, Cui X. The role of microbiota in respiratory health and diseases, particularly in tuberculosis. Biomed Pharmacother. 2021;143:112108. https:\/\/doi.org\/10.1016\/j.biopha.2021.112108.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"4091_CR10","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00018-019-03370-4","volume":"77","author":"OA Eribo","year":"2020","unstructured":"Eribo OA, du Plessis N, Ozturk M, Guler R, Walzl G, Chegou NN. The gut Microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty? Cell Mol Life Sci. 2020;77(8):1497\u2013509. https:\/\/doi.org\/10.1007\/s00018-019-03370-4.","journal-title":"Cell Mol Life Sci"},{"key":"4091_CR11","volume-title":"WHO consolidated guidelines on tuberculosis: module 4: Treatment - Drug-resistant tuberculosis treatment","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: module 4: Treatment - Drug-resistant tuberculosis treatment. Geneva: World Health Organization; 2020."},{"key":"4091_CR12","doi-asserted-by":"publisher","unstructured":"Wang J, Wang Y, Ling X, Zhang Z, Deng Y. Comparison of sputum treated with power ultrasound and routine NALC-NaOH methods for mycobacterial culture: A prospective study. 2022;11(16). https:\/\/doi.org\/10.3390\/jcm11164694.","DOI":"10.3390\/jcm11164694"},{"issue":"1","key":"4091_CR13","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12866-022-02705-9","volume":"22","author":"X Cai","year":"2022","unstructured":"Cai X, Luo Y, Zhang Y, Lin Y, Wu B, Cao Z, et al. Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients. BMC Microbiol. 2022;22(1):286. https:\/\/doi.org\/10.1186\/s12866-022-02705-9.","journal-title":"BMC Microbiol"},{"key":"4091_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4939-8728-3_8","volume":"1849","author":"M Hall","year":"2018","unstructured":"Hall M, Beiko RG. 16S rRNA gene analysis with QIIME2. Methods Mol Biol. 2018;1849:113\u201329. https:\/\/doi.org\/10.1007\/978-1-4939-8728-3_8.","journal-title":"Methods Mol Biol"},{"key":"4091_CR15","doi-asserted-by":"publisher","unstructured":"Douglas GM, Maffei VJ. PICRUSt2 for prediction of metagenome functions. 2020;38(6):685\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0548-6.","DOI":"10.1038\/s41587-020-0548-6"},{"key":"4091_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/2049-2618-2-29","volume":"2","author":"LE Botero","year":"2014","unstructured":"Botero LE, Delgado-Serrano L, Cepeda ML, Bustos JR, Anzola JM, Del Portillo P, et al. Respiratory tract clinical sample selection for microbiota analysis in patients with pulmonary tuberculosis. Microbiome. 2014;2:29. https:\/\/doi.org\/10.1186\/2049-2618-2-29.","journal-title":"Microbiome"},{"issue":"5","key":"4091_CR17","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.jaci.2020.03.028","volume":"146","author":"J Durack","year":"2020","unstructured":"Durack J, Christian LS, Nariya S, Gonzalez J, Bhakta NR, Ansel KM, et al. Distinct associations of sputum and oral microbiota with atopic, immunologic, and clinical features in mild asthma. J Allergy Clin Immunol. 2020;146(5):1016\u201326. https:\/\/doi.org\/10.1016\/j.jaci.2020.03.028.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"4091_CR18","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.1038\/s41598-023-34052-8","volume":"13","author":"C Ruiz-Tagle","year":"2023","unstructured":"Ruiz-Tagle C, Ugalde JA, Naves R, Araos R, Garc\u00eda P, Balcells ME. Reduced microbial diversity of the nasopharyngeal Microbiome in household contacts with latent tuberculosis infection. Sci Rep. 2023;13(1):7301. https:\/\/doi.org\/10.1038\/s41598-023-34052-8.","journal-title":"Sci Rep"},{"key":"4091_CR19","doi-asserted-by":"publisher","first-page":"102231","DOI":"10.1016\/j.tube.2022.102231","volume":"136","author":"Y Huang","year":"2022","unstructured":"Huang Y, Tang JH, Cai Z, Qi Y, Jiang S, Ma TT, et al. Alterations in the nasopharyngeal microbiota associated with active and latent tuberculosis. Tuberc (Edinb Scotl). 2022;136:102231. https:\/\/doi.org\/10.1016\/j.tube.2022.102231.","journal-title":"Tuberc (Edinb Scotl)"},{"issue":"2","key":"4091_CR20","doi-asserted-by":"publisher","first-page":"110816","DOI":"10.1016\/j.ygeno.2024.110816","volume":"116","author":"M Shahzad","year":"2024","unstructured":"Shahzad M, Saeed M, Amin H, Binmadi N, Ullah Z, Bibi S, et al. The oral Microbiome of newly diagnosed tuberculosis patients; a pilot study. Genomics. 2024;116(2):110816. https:\/\/doi.org\/10.1016\/j.ygeno.2024.110816.","journal-title":"Genomics"},{"issue":"1","key":"4091_CR21","doi-asserted-by":"publisher","first-page":"e0190121","DOI":"10.1128\/spectrum.01901-21","volume":"10","author":"G Xiao","year":"2022","unstructured":"Xiao G, Cai Z, Guo Q, Ye T, Tang Y, Guan P, et al. Insights into the unique lung microbiota profile of pulmonary tuberculosis patients using metagenomic Next-Generation sequencing. Microbiol Spectr. 2022;10(1):e0190121. https:\/\/doi.org\/10.1128\/spectrum.01901-21.","journal-title":"Microbiol Spectr"},{"key":"4091_CR22","doi-asserted-by":"publisher","first-page":"106475","DOI":"10.1016\/j.rmed.2021.106475","volume":"185","author":"JL Pathak","year":"2021","unstructured":"Pathak JL, Yan Y, Zhang Q, Wang L, Ge L. The role of oral Microbiome in respiratory health and diseases. Respir Med. 2021;185:106475. https:\/\/doi.org\/10.1016\/j.rmed.2021.106475.","journal-title":"Respir Med"},{"issue":"1","key":"4091_CR23","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/22221751.2020.1737578","volume":"9","author":"T Qin","year":"2020","unstructured":"Qin T, Geng T, Zhou H, Han Y, Ren H, Qiu Z, et al. Super-dominant pathobiontic bacteria in the nasopharyngeal microbiota as causative agents of secondary bacterial infection in influenza patients. Emerg Microbes Infections. 2020;9(1):605\u201315. https:\/\/doi.org\/10.1080\/22221751.2020.1737578.","journal-title":"Emerg Microbes Infections"},{"issue":"7","key":"4091_CR24","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s10096-016-2654-4","volume":"35","author":"P Krishna","year":"2016","unstructured":"Krishna P, Jain A, Bisen PS. Microbiome diversity in the sputum of patients with pulmonary tuberculosis. Eur J Clin Microbiol Infect Dis. 2016;35(7):1205\u201310. https:\/\/doi.org\/10.1007\/s10096-016-2654-4.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4091_CR25","doi-asserted-by":"publisher","unstructured":"Teskey G, Abrahem R, Cao R, Gyurjian K, Islamoglu H, Lucero M et al. Glutathione as a marker for human disease. Advances in clinical chemistry. 2018;87:141\u201359. https:\/\/doi.org\/10.1016\/bs.acc.2018.07.004.","DOI":"10.1016\/bs.acc.2018.07.004"},{"issue":"1","key":"4091_CR26","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1038\/s41598-024-53880-w","volume":"14","author":"V Sawaswong","year":"2024","unstructured":"Sawaswong V, Chanchaem P, Klomkliew P, Rotcheewaphan S, Meesawat S, Kemthong T, et al. Full-length 16S rDNA sequencing based on Oxford nanopore technologies revealed the association between gut-pharyngeal microbiota and tuberculosis in cynomolgus macaques. Sci Rep. 2024;14(1):3404. https:\/\/doi.org\/10.1038\/s41598-024-53880-w.","journal-title":"Sci Rep"},{"key":"4091_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.micpath.2018.04.054","volume":"120","author":"M Nakhaee","year":"2018","unstructured":"Nakhaee M, Rezaee A, Basiri R, Soleimanpour S, Ghazvini K. Relation between lower respiratory tract microbiota and type of immune response against tuberculosis. Microb Pathog. 2018;120:161\u20135. https:\/\/doi.org\/10.1016\/j.micpath.2018.04.054.","journal-title":"Microb Pathog"},{"issue":"Pt 6","key":"4091_CR28","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1099\/jmm.0.039693-0","volume":"61","author":"JS Cargill","year":"2012","unstructured":"Cargill JS, Scott KS, Gascoyne-Binzi D, Sandoe JAT. Granulicatella infection: diagnosis and management. J Med Microbiol. 2012;61(Pt 6):755\u201361. https:\/\/doi.org\/10.1099\/jmm.0.039693-0.","journal-title":"J Med Microbiol"},{"issue":"4","key":"4091_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ihj.2013.06.014","volume":"65","author":"TS Shailaja","year":"2013","unstructured":"Shailaja TS, Sathiavathy KA, Unni G. Infective endocarditis caused by Granulicatella adiacens. Indian Heart J. 2013;65(4):447\u20139. https:\/\/doi.org\/10.1016\/j.ihj.2013.06.014.","journal-title":"Indian Heart J"},{"key":"4091_CR30","doi-asserted-by":"publisher","unstructured":"Yoon H, Park YS. Gut Microbiome in probable intestinal tuberculosis and changes following Anti-Tuberculosis treatment. 2022;63(1):34\u201341. https:\/\/doi.org\/10.3349\/ymj.2022.63.1.34.","DOI":"10.3349\/ymj.2022.63.1.34"},{"key":"4091_CR31","doi-asserted-by":"publisher","unstructured":"Yang D, Xing Y, Song X, Qian Y. The impact of lung microbiota dysbiosis on inflammation. 2020;159(2):156\u201366. https:\/\/doi.org\/10.1111\/imm.13139.","DOI":"10.1111\/imm.13139"},{"key":"4091_CR32","doi-asserted-by":"publisher","unstructured":"Carmody LA, Caverly LJ, Foster BK, Rogers MAM, Kalikin LM, Simon RH et al. Fluctuations in airway bacterial communities associated with clinical States and disease stages in cystic fibrosis. 2018;13(3):e0194060. https:\/\/doi.org\/10.1371\/journal.pone.0194060.","DOI":"10.1371\/journal.pone.0194060"},{"issue":"11","key":"4091_CR33","doi-asserted-by":"publisher","first-page":"e22124","DOI":"10.1016\/j.heliyon.2023.e22124","volume":"9","author":"Y Huang","year":"2023","unstructured":"Huang Y, Tang J, Cai Z, Qi Y, Jiang S, Ma T, et al. Alterations in the intestinal microbiota associated with active tuberculosis and latent tuberculosis infection. Heliyon. 2023;9(11):e22124. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22124.","journal-title":"Heliyon"},{"key":"4091_CR34","doi-asserted-by":"publisher","unstructured":"Li Y, Zhao L, Hou M, Gao T, Sun J, Luo H et al. Lactobacillus casei improve Anti-Tuberculosis Drugs-Induced intestinal adverse reactions in rat by modulating gut microbiota and Short-Chain fatty acids. 2022;14(8). https:\/\/doi.org\/10.3390\/nu14081668.","DOI":"10.3390\/nu14081668"},{"key":"4091_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2016.10.016","volume":"102","author":"SH Lee","year":"2016","unstructured":"Lee SH, Sung JY, Yong D, Chun J, Kim SY, Song JH, et al. Characterization of Microbiome in Bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung cancer (Amsterdam Netherlands). 2016;102:89\u201395. https:\/\/doi.org\/10.1016\/j.lungcan.2016.10.016.","journal-title":"Lung cancer (Amsterdam Netherlands)"},{"issue":"11","key":"4091_CR36","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1164\/rccm.201505-0943OC","volume":"192","author":"B Mirkovi\u0107","year":"2015","unstructured":"Mirkovi\u0107 B, Murray MA, Lavelle GM, Molloy K, Azim AA, Gunaratnam C, et al. The role of Short-Chain fatty acids, produced by anaerobic bacteria, in the cystic fibrosis airway. Am J Respir Crit Care Med. 2015;192(11):1314\u201324. https:\/\/doi.org\/10.1164\/rccm.201505-0943OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"4091_CR37","doi-asserted-by":"publisher","unstructured":"Maraki S, Papadakis IS. Rothia mucilaginosa pneumonia: a literature review. Infectious diseases (London, England). 2015;47(3):125-9. https:\/\/doi.org\/10.3109\/00365548.2014.980843.","DOI":"10.3109\/00365548.2014.980843"},{"key":"4091_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3389\/fcimb.2019.00090","volume":"9","author":"Y Hu","year":"2019","unstructured":"Hu Y, Feng Y, Wu J, Liu F, Zhang Z, Hao Y, et al. The gut Microbiome signatures discriminate healthy from pulmonary tuberculosis patients. Front Cell Infect Microbiol. 2019;9:90. https:\/\/doi.org\/10.3389\/fcimb.2019.00090.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4091_CR39","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/1462-2920.14015","volume":"20","author":"A Maji","year":"2018","unstructured":"Maji A, Misra R, Dhakan DB, Gupta V, Mahato NK, Saxena R, et al. Gut Microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers. Environ Microbiol. 2018;20(1):402\u201319. https:\/\/doi.org\/10.1111\/1462-2920.14015.","journal-title":"Environ Microbiol"},{"key":"4091_CR40","doi-asserted-by":"publisher","unstructured":"Keenan MJ, Marco ML, Ingram DK, Martin RJ. Improving healthspan via changes in gut microbiota and fermentation. 2015;37(5):98.\u00a0https:\/\/doi.org\/10.1007\/s11357-015-9817-6.","DOI":"10.1007\/s11357-015-9817-6"},{"key":"4091_CR41","doi-asserted-by":"publisher","first-page":"6014631","DOI":"10.1155\/2016\/6014631","volume":"2016","author":"E Lachmandas","year":"2016","unstructured":"Lachmandas E, van den Heuvel CN, Damen MS, Cleophas MC, Netea MG, van Crevel R. Diabetes mellitus and increased tuberculosis susceptibility: the role of Short-Chain fatty acids. J Diabetes Res. 2016;2016:6014631. https:\/\/doi.org\/10.1155\/2016\/6014631.","journal-title":"J Diabetes Res"},{"key":"4091_CR42","doi-asserted-by":"publisher","unstructured":"Sala C, Benjak A, Goletti D, Banu S, Mazza-Stadler J, Jaton K et al. Multicenter analysis of sputum microbiota in tuberculosis patients. 2020;15(10):e0240250.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0240250.","DOI":"10.1371\/journal.pone.0240250"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04091-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:47:35Z","timestamp":1751377655000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-04091-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4091"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04091-4","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study protocols were approved by the Human Ethics Committee of Guangzhou Chest Hospital and adhered to the principles outlined in the Helsinki Declaration. Informed consent forms were signed by all participants. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}